500.02 Clinical Outcomes At 2 Years of The Absorb Bioresorbable Vascular Scaffold Versus The Xience Drug-eluting Metallic Stent In Patients Presenting With Acute Coronary Syndrome Versus Stable Coronary Disease - Aida Trial Sub-study.

R. Tijssen, René J. van der Schaaf, Robin P. Kraak, M Vink, Sjoerd H. Hofma, Karin Arkenbout, Auke Weevers, Laura S.M. Kerkmeijer, Patrick W. Serruys, Yoshinobu Onuma, Marcel A.M. Beijk, Karel T. Koch, Jan Baan, Marije M. Vis, Jan J. Piek, Jan G.P. Tijssen, José P.S. Henriques, Robbert J. de Winter, Joanna J. Wykrzykowska (2019). 500.02 Clinical Outcomes At 2 Years of The Absorb Bioresorbable Vascular Scaffold Versus The Xience Drug-eluting Metallic Stent In Patients Presenting With Acute Coronary Syndrome Versus Stable Coronary Disease - Aida Trial Sub-study.. КАРДИОЛОГИЯ УЗБЕКИСТАНА, 12(4), pp. S39-S39, DOI: 10.1016/j.jcin.2019.01.141.